Back to search
FDAFDA · Food and drugs·Recall number D-1123-2015

Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT

Published June 17, 2015 · Recall initiated: May 15, 2015

Summary

FDA records drug Class II recall D-1123-2015, published June 17, 2015 and initiated May 15, 2015. Recalling firm: Montana Compounding Pharmacy; Status: Terminated; Reported quantity: 20/1 mL vials; Lot: Lot 02062015:06@3, expiry date: 5/17/2015; Lot 02272015:93@1, expiry date: 6/30/2015; Lot 03252015:92@7, expiry date: 6/30/2015; Lot 04162015:63@7, expiry date: 6/30/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Montana Compounding Pharmacy
Distributor
MT and ND
Lot
Lot 02062015:06@3, expiry date: 5/17/2015; Lot 02272015:93@1, expiry date: 6/30/2015; Lot 03252015:92@7, expiry date: 6/30/2015; Lot 04162015:63@7, expiry date: 6/30/2015.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT recalled?

Yes. FDA published recall D-1123-2015 on June 17, 2015. Reported hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

What should I do if I have this product?

Voluntary: Firm initiated · Letter